Suppr超能文献

分析用于药物转运和毒性体外研究的肾近端小管微生理系统 OrganoPlate 3 道 40 的可重复性和稳健性。

Analysis of reproducibility and robustness of a renal proximal tubule microphysiological system OrganoPlate 3-lane 40 for in vitro studies of drug transport and toxicity.

机构信息

Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, Texas 77843, USA.

Bioinformatics Research Center, North Carolina State University, Raleigh, North Carolina 27695, USA.

出版信息

Toxicol Sci. 2023 Oct 30;196(1):52-70. doi: 10.1093/toxsci/kfad080.

Abstract

Microphysiological systems are an emerging area of in vitro drug development, and their independent evaluation is important for wide adoption and use. The primary goal of this study was to test reproducibility and robustness of a renal proximal tubule microphysiological system, OrganoPlate 3-lane 40, as an in vitro model for drug transport and toxicity studies. This microfluidic model was compared with static multiwell cultures and tested using several human renal proximal tubule epithelial cell (RPTEC) types. The model was characterized in terms of the functional transport for various tubule-specific proteins, epithelial permeability of small molecules (cisplatin, tenofovir, and perfluorooctanoic acid) versus large molecules (fluorescent dextrans, 60-150 kDa), and gene expression response to a nephrotoxic xenobiotic. The advantages offered by OrganoPlate 3-lane 40 as compared with multiwell cultures are the presence of media flow, albeit intermittent, and increased throughput compared with other microfluidic models. However, OrganoPlate 3-lane 40 model appeared to offer only limited (eg, MRP-mediated transport) advantages in terms of either gene expression or functional transport when compared with the multiwell plate culture conditions. Although OrganoPlate 3-lane 40 can be used to study cellular uptake and direct toxic effects of small molecules, it may have limited utility for drug transport studies. Overall, this study offers refined experimental protocols and comprehensive comparative data on the function of RPETCs in traditional multiwell culture and microfluidic OrganoPlate 3-lane 40, information that will be invaluable for the prospective end-users of in vitro models of the human proximal tubule.

摘要

微生理系统是体外药物开发的一个新兴领域,对其进行独立评估对于广泛采用和使用至关重要。本研究的主要目的是测试肾近端小管微生理系统 OrganoPlate 3-lane 40 的重现性和稳健性,作为药物转运和毒性研究的体外模型。该微流控模型与静态多孔培养物进行了比较,并使用几种人肾近端小管上皮细胞 (RPTEC) 类型进行了测试。该模型在各种管状特异性蛋白的功能转运、小分子(顺铂、替诺福韦和全氟辛酸)与大分子(荧光葡聚糖,60-150 kDa)的上皮通透性以及对肾毒性异生物质的基因表达反应方面进行了表征。与多孔培养物相比,OrganoPlate 3-lane 40 提供的优势是存在介质流动,尽管是间歇性的,并且与其他微流控模型相比,通量增加。然而,与多孔板培养条件相比,OrganoPlate 3-lane 40 模型在基因表达或功能转运方面似乎仅提供有限的(例如,MRP 介导的转运)优势。尽管 OrganoPlate 3-lane 40 可用于研究小分子的细胞摄取和直接毒性作用,但它在药物转运研究中可能具有有限的用途。总体而言,本研究提供了有关 RPETCs 在传统多孔培养物和微流控 OrganoPlate 3-lane 40 中的功能的改良实验方案和综合比较数据,这些信息对于人类近端小管体外模型的预期最终用户将是非常宝贵的。

相似文献

3
Management of urinary stones by experts in stone disease (ESD 2025).
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
5
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
6
The Black Book of Psychotropic Dosing and Monitoring.
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.

引用本文的文献

1
2
Human and rat renal proximal tubule in vitro models for ADME applications.
Arch Toxicol. 2025 May;99(5):1613-1641. doi: 10.1007/s00204-025-03987-4. Epub 2025 Mar 4.
4
Progress in toxicogenomics to protect human health.
Nat Rev Genet. 2025 Feb;26(2):105-122. doi: 10.1038/s41576-024-00767-1. Epub 2024 Sep 2.
6
Neuropathogenesis-on-chips for neurodegenerative diseases.
Nat Commun. 2024 Mar 12;15(1):2219. doi: 10.1038/s41467-024-46554-8.

本文引用的文献

2
Microphysiological Systems Evaluation: Experience of TEX-VAL Tissue Chip Testing Consortium.
Toxicol Sci. 2022 Jul 28;188(2):143-152. doi: 10.1093/toxsci/kfac061.
3
Kidney metabolism and acid-base control: back to the basics.
Pflugers Arch. 2022 Aug;474(8):919-934. doi: 10.1007/s00424-022-02696-6. Epub 2022 May 5.
5
Grouping of UVCB substances with dose-response transcriptomics data from human cell-based assays.
ALTEX. 2022;39(3):388–404. doi: 10.14573/altex.2107051. Epub 2022 Mar 10.
6
How Many Cell Types Are in the Kidney and What Do They Do?
Annu Rev Physiol. 2022 Feb 10;84:507-531. doi: 10.1146/annurev-physiol-052521-121841. Epub 2021 Nov 29.
7
Prediction of hepatic drug clearance with a human microfluidic four-cell liver acinus microphysiology system.
Toxicology. 2021 Nov;463:152954. doi: 10.1016/j.tox.2021.152954. Epub 2021 Sep 17.
9
A 3D Renal Proximal Tubule on Chip Model Phenocopies Lowe Syndrome and Dent II Disease Tubulopathy.
Int J Mol Sci. 2021 May 19;22(10):5361. doi: 10.3390/ijms22105361.
10
Microphysiological systems: What it takes for community adoption.
Exp Biol Med (Maywood). 2021 Jun;246(12):1435-1446. doi: 10.1177/15353702211008872. Epub 2021 Apr 25.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验